Bioventus Inc - Ordinary Shares - Class A

-0.33 (-1.84%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)978.93M
Current PE34.03
Forward PE 12.5
2yr Forward PE 14.21
See more stats
Estimates Current Quarter
Revenue$98.27 Million
Adjusted EPS$0.13
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Bioventus Inc - Ordinary Shares - Class A Stock, NASDAQ:BVS

4721 Emperor Boulevard, Suite 100, Durham, North Carolina 27703
United States of America
Phone: +1.919.474.6700
Number of Employees: 700


Bioventus, Inc. global medical technology company which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from a array of musculoskeletal conditions. It operates through four segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on December 22, 2015 and is headquartered in Durham, NC.